Publication | Closed Access

Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma

Cell TherapyTransplantationMarrow TransplantationMolecular RemissionImmunologyHematologyMultiple MyelomaGraft SurvivalImmunotherapyMedicineCell TransplantationGraft RejectionPost-transplant Immunotherapy